2008: Treatment and Etiology of Fibromyalgia Syndrome
Search or Browse by Day

Treatment and Etiology of Fibromyalgia Syndrome

Sunday, October 26, 2008
582
Milnacipran Improves Pain in Fibromyalgia Patients: Patient E-diary Results Over 15 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Trials
583
Improvements in Fibromyalgia Symptoms Are Sustained for 1 Year with Milnacipran Treatment: Results From a Dose-Controlled, Extension Study
584
Milnacipran Improves Fatigue in Patients with Fibromyalgia: Results from Two Randomized, Double-Blind, Placebo-Controlled Trials
585
The Effect of Milnacipran Therapy on Body Weight and Body Mass Index in Two Randomized, Double-Blind, Placebo-Controlled Trials
586
The Beneficial Effect of Milnacipran on Fibromyalgia Syndrome is not Related with Antidepressant Properties: A European Multicenter, Double-Blind, Placebo-Controlled Trial
587
Estimation of Minimum Clinically Important Difference of Pain in Fibromyalgia
588
Impact of Duloxetine Treatment on Concentration and Mental Fatigue in Patients with Fibromyalgia
589
Dual Versus Mono Responders In Fibromyalgia Patients With Major Depressive Disorder
590
Patients With Fibromyalgia: Baseline Observations From an International Randomized Controlled Trial (RCT) of Pregabalin (Lyrica®)
591
Is Pregabalin Better than Conventional Therapy in Fibromyalgia?
592
Pregabalin (Lyrica®) Monotherapy for Management of Fibromyalgia: Results From a 14-week Randomized, Double-blind, Placebo-controlled International Trial
593
Do Fibromyalgia Patients Have A Genetic Predisposition To The Illness?
594
Adverse Childhood Environment In Fibromyalgia Patients
595
Heart Rate Variability Is Not Superior To Classic Autonomic Testing In Patients With Fibromyalgia
596
Transition from Chronic Axial Pain to Widespread Pain Over a Period of 5 Years: An Analysis of 320 Patients Seen in a Pain Clinic
597
Evidence of Abnormal Epidermal Nerve Fiber Density (ENFD) in Fibromyalgia
598
Pathological Compulsive Behavior Associated with Dopamine Agonists Used to Treat Fibromyalgia
599
Autonomic Dysfunction in Fibromyalgia Assessed by the “Composite Autonomic Symptom Scale (COMPASS)”
600
A Meta-analysis of Efficacy and Safety in the Treatment of Fibromyalgia
601
Does a Subnormal Stimulated Growth Hormone (GH) Response in Fibromyalgia Indicate GH Deficiency?
602
The Efficacy of Periodic Acceleration and Craniosacral Massage for Treatment of Fibromyalgia
603
Improvement In Pain-related Symptoms Following A Multidisciplinay Treatment Programme In Fibromyalgia Patients:one Year Follow Up
604
Efficacy And Safety Of Steroid Injections For Shoulder And Elbow Tendonitis: A Meta-analysis Of Randomized Controlled Trials
605
Exploration of Possible Relationships Between Pain and Mood: a Pooled Analysis of 3 Trials of Pregabalin (Lyrica®) as Treatment of Fibromyalgia
606
Milnacipran Reduces Fatigue in Patients with Fibromyalgia: Electronic Diary Results
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>